Five Institutions To Receive Support For iPS Regenerative Research From Japanese Government
This article was originally published in PharmAsia News
Executive Summary
The Japanese government decided on five institutions that will receive support for clinical research using iPS cells as the country strives to make the breakthrough discovery a new industry.